Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05637333

Sonazoid in Myocardial Perfusion Imaging

Conditions: Diagnostic Imaging, Myocardial Ischemia

Sex: All
Ages: 18 Years – N/A
Enrollment: 10
Sponsor: London North West Healthcare NHS Trust

Location: United Kingdom

Summary

Currently, Sonazoid is mainly used for imaging liver lesions by assessing perfusion characteristics. However, the ultrasound technology is the same as for cardiac imaging and the stability of the microbubbles will potentially aid the detection of myocardial perfusion defects. This study will look at the feasibility of using sonozoid in this way.

Eligibility Criteria

Inclusion Criteria:Positive and normal Clinical SEAble to provide informed consentExclusion Criteria:Unable / unwilling to give informed consentAllergy to PerfluorobutaneEgg allergyPatients with right to left arteriovenous cardiac or pulmonary shuntUnstable heart diseaseSerious pulmonary diseasePregnancy or lactation Women of child bearing potential (defined as not chemically or surgically sterilised or post menopausal)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05637333). StuddyBuddy aggregates publicly available trial information.